Daily Goal Setting to Increase Everyday Physical Activity and Promote Cognitive Health in Midlife
NCT ID: NCT05826379
Last Updated: 2025-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
200 participants
INTERVENTIONAL
2024-03-20
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
NCT05980052
Community-based Intervention Effects on Older Adults' Physical Activity
NCT03326141
Exercise Treatment of Mild-Stage Probable Alzheimer's Disease
NCT00403507
Changes in Habitual Physical Activity and Inactivity
NCT01580930
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
NCT05877196
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To support goal maintenance our team has developed a Fitbit application designed to operate on the Fitbit Versa series watch as a 'clockface'. The application will first calibrate participants' average level of physical activity by recording daily step counts for a period of 14 days (calibration phase). After this period (and following a health education session) the application will begin delivering the underlying intervention to both treatment and control groups for a period of 1 month. The intervention is composed of daily step goals presented via the Fitbit clockface. Each day the application will suggest a daily step goal. The algorithm used to make these suggestions relies on the participant's own activity during the calibration period and is updated each day in study, ensuring all proposed step goals are within their existing repertoire. Follow-up assessments will be completed at 1- and 12-monts post-intervention.
Outcomes and moderators will be measured via activity monitors (the Fitbit application and activPals), surveys, and ecological momentary assessments (self-ratings and performance-based ambulatory cognitive assessments) conducted via the Mobile Monitoring of Cognitive Change ("M2C2") platform.
Some of the details of the intervention, algorithm, experimental manipulations, and outcomes have been omitted to preserve the scientific integrity of the study. These details will be added after the study is closed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants receive the adaptive daily step goal mHealth intervention
Adaptive Daily Goal Setting
Daily step goals displayed by the study application
Treatment
Participants receive the adaptive daily step goal mHealth intervention plus interim goal setting prompts each day
Adaptive Daily Goal Setting
Daily step goals displayed by the study application
Interim Goal Prompt
Short-term step goals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adaptive Daily Goal Setting
Daily step goals displayed by the study application
Interim Goal Prompt
Short-term step goals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≥ 25
Exclusion Criteria
* Health condition contraindicated for increased physical activity
* Medical conditions or medications that would prohibit participation in an exercise test (e.g., decompensated heart failure, severe aortic stenosis, uncontrolled arrhythmia, and acute coronary syndromes)
* Limitations in use of a smart phone (e.g., issues with manual dexterity or visual impairment)
* Inability to walk unassisted
* BMI \> 50
* Plan to have surgery or other procedure over the next 12 months that could affect mobility or light intensity physical activity maintenance
* Concurrent participation in a weight loss, physical activity, or cognitive training trial
* Failure to comply with Run-in Period activity monitoring (\<70% valid wear days for the Fitbit and activPal)
* Anyone who will not discontinue the use of their own personal smartwatch during the training period.
* Anyone who scores below 19 on the MoCA-B would not be randomized after the Run-in Calibration Period.
Note: The eligibility criteria are deliberately incomplete to preserve the scientific integrity of the study. These details will be added after study closure.
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute on Aging (NIA)
NIH
Milton S. Hershey Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Hakun
Assistant Professor of Neurology, Psychology, & Public Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan G Hakun, PhD
Role: PRINCIPAL_INVESTIGATOR
Milton S. Hershey Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00022087
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.